Results 161 to 170 of about 140,766 (264)

Ten‐Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits Scheme

Clinical Pharmacology &Therapeutics, EarlyView.
Biologic therapies are a major and growing driver of pharmaceutical expenditure globally, with tumor necrosis factor (TNF) inhibitors among the most widely used and costly biologics. In Australia, these therapies are funded through the Pharmaceutical Benefits Scheme (PBS), where biosimilars offer lower cost alternatives; however, the long‐term public ...
Chin Hang Yiu, Bella D. Ianni, Richard O. Day, Jacques Raubenheimer, Christine Y. Lu   +4 more
wiley   +1 more source

Socioeconomic Determinants of Access to Medicines Among Romanian Patients with Chronic Diseases: A Cross-Sectional Study. [PDF]

Healthcare (Basel)
Negrila CD, Gherasie LM, Armean SM, Armean P.   +3 more
europepmc   +1 more source

Green Human Resource Management (GHRM) and Environment Social Governance (ESG): A Systematic Literature Review

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This paper presents a systematic literature review exploring the intersection of Green Human Resource Management (GHRM) and Environmental, Social, and Governance (ESG) criteria. The study synthesizes current research, identifies prevailing trends, and highlights gaps within this emerging field.
Zile Huma, Emma Garcia Meca, Jennifer Martínez‐Ferrero, Nazim Hussain   +3 more
wiley   +1 more source

Does ESG Performance Reduce Default Risk in Insurance Firms? Evidence From Life and Non‐Life Sectors

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study examines whether environmental, social, and governance performance is associated with lower default risk in European insurance firms, and whether the strength of this association differs between life and non‐life business models.
S. Miani, M. Mantovani, E. Palmieri
wiley   +1 more source

Ethical perceptions of DRG-based hospital financing among physicians and hospital managers in Germany: a cross-sectional survey. [PDF]

BMC Med Ethics
Becker S, Lemm H, Stang A, Sossalla S, Buerke M, Boettger P.   +5 more
europepmc   +1 more source

Use of the Ion Robot in the Diagnosis of Pulmonary Nodules: Fine Needle Aspiration Versus Cryobiopsy

Diagnostic Cytopathology, EarlyView.
ABSTRACT Background Robotic‐assisted bronchoscopy platforms provide an innovative approach to the sampling of pulmonary nodules. As compared to other technologies, fiber‐optic shape‐sensing instrumentation allows for a more precise, accurate location and sampling of the target lesion with fewer complications.
Suzanne M. Selvaggi
wiley   +1 more source

Residents' preferences for inclusive commercial supplementary medical insurance: a discrete choice experiment. [PDF]

Health Econ Rev
Feng Y, Li G, Wu S, Sun Q, Xi X, Wang E.
europepmc   +1 more source

Unveiling spatial heterogeneity in urban underground space development patterns and mechanisms for differentiated planning: A points of interest‐based study of Shanghai

Deep Underground Science and Engineering, EarlyView.
This study investigated the spatial patterns and development mechanisms of urban underground space (UUS) in Shanghai using underground points of interest data. It revealed distinct development mechanisms between the main city and suburbs, highlighting the need for differentiated UUS planning and policies to optimize underground space resources ...
Chenxiao Ma, Fangle Peng, Yongkang Qiao, Yunhao Dong   +3 more
wiley   +1 more source

Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis. [PDF]

Rheumatology (Oxford)
Schmalzing M, Moinzadeh P, Weliwitage J, Henes J, Blank N, Keysser G, Riemekasten G, Mueller-Ladner U, Worm M, Juche A, Kreuter A, Ehrchen J, Susok L, Guenther C, Zeidler G, Jandova I, Schmeiser T, Pfeiffer C, Koetter I, Alberding A, Distler JHW, Hunzelmann N, DNSS Study Group.   +22 more
europepmc   +1 more source